Literature DB >> 22378855

EuroSCORE II.

Samer A M Nashef1, François Roques, Linda D Sharples, Johan Nilsson, Christopher Smith, Antony R Goldstone, Ulf Lockowandt.   

Abstract

OBJECTIVES: To update the European System for Cardiac Operative Risk Evaluation (EuroSCORE) risk model.
METHODS: A dedicated website collected prospective risk and outcome data on 22,381 consecutive patients undergoing major cardiac surgery in 154 hospitals in 43 countries over a 12-week period (May-July 2010). Completeness and accuracy were validated during data collection using mandatory field entry, error and range checks and after data collection using summary feedback confirmation by responsible officers and multiple logic checks. Information was obtained on existing EuroSCORE risk factors and additional factors proven to influence risk from research conducted since the original model. The primary outcome was mortality at the base hospital. Secondary outcomes were mortality at 30 and 90 days. The data set was divided into a developmental subset for logistic regression modelling and a validation subset for model testing. A logistic risk model (EuroSCORE II) was then constructed and tested.
RESULTS: Compared with the original 1995 EuroSCORE database (in brackets), the mean age was up at 64.7 (62.5) with 31% females (28%). More patients had New York Heart Association class IV, extracardiac arteriopathy, renal and pulmonary dysfunction. Overall mortality was 3.9% (4.6%). When applied to the current data, the old risk models overpredicted mortality (actual: 3.9%; additive predicted: 5.8%; logistic predicted: 7.57%). EuroSCORE II was well calibrated on testing in the validation data subset of 5553 patients (actual mortality: 4.18%; predicted: 3.95%). Very good discrimination was maintained with an area under the receiver operating characteristic curve of 0.8095.
CONCLUSIONS: Cardiac surgical mortality has significantly reduced in the last 15 years despite older and sicker patients. EuroSCORE II is better calibrated than the original model yet preserves powerful discrimination. It is proposed for the future assessment of cardiac surgical risk.

Entities:  

Mesh:

Year:  2012        PMID: 22378855     DOI: 10.1093/ejcts/ezs043

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  453 in total

1.  sST2 as a novel biomarker for the prediction of in-hospital mortality after coronary artery bypass grafting.

Authors:  Meagan E Stabler; Michael E Rezaee; Devin M Parker; Todd A MacKenzie; Andrew R Bohm; Anthony W DiScipio; David J Malenka; Jeremiah R Brown
Journal:  Biomarkers       Date:  2019-01-11       Impact factor: 2.658

2.  Long-term antibiotic therapy in patients with surgery-indicated not undergoing surgery infective endocarditis.

Authors:  Nuria Vallejo Camazon; Lourdes Mateu; Germán Cediel; Laura Escolà-Vergé; Nuria Fernández-Hidalgo; Mercedes Gurgui Ferrer; Maria Teresa Perez Rodriguez; Guillermo Cuervo; Raquel Nuñez Aragón; Cinta Llibre; Nieves Sopena; Maria Dolores Quesada; Elisabeth Berastegui; Albert Teis; Jorge Lopez Ayerbe; Gladys Juncà; Francisco Gual; Elena Ferrer Sistach; Ainhoa Vivero; Esteban Reynaga; Maria Hernández Pérez; Christian Muñoz Guijosa; Lluisa Pedro-Botet; Antoni Bayés-Genís
Journal:  Cardiol J       Date:  2021-05-25       Impact factor: 2.737

3.  Report from AmSECT's International Consortium for Evidence- Based Perfusion Consensus Statement: Minimal Criteria for Reporting Cardiopulmonary Bypass-Related Contributions to Red Blood Cell Transfusions Associated With Adult Cardiac Surgery.

Authors:  Donald S Likosky; Robert A Baker; Timothy A Dickinson; Daniel J FitzGerald; M Filip De Somer; Robert C Groom; David FitzGerald; Kenneth G Shann; Michael Poullis; Bruce D Spiess; Karim Jabr; Mark T Lucas; James D Ferguson; Shahna L Bronson
Journal:  J Extra Corpor Technol       Date:  2015-06

4.  Different responses of the myocardial contractility by layer following acute pressure unloading in severe aortic stenosis patients.

Authors:  Hyun-Jin Kim; Seung-Pyo Lee; Chan Soon Park; Jun-Bean Park; Yong-Jin Kim; Hyung-Kwan Kim; Dae-Won Sohn
Journal:  Int J Cardiovasc Imaging       Date:  2015-09-01       Impact factor: 2.357

5.  Performance of EuroSCORE II compared to EuroSCORE I in predicting operative and mid-term mortality of patients from a single center after combined coronary artery bypass grafting and aortic valve replacement.

Authors:  Kyriakos Spiliopoulos; Vasilis Bagiatis; Oliver Deutsch; Bernhard M Kemkes; Nikolaos Antonopoulos; Dimos Karangelis; Ayman Haschemi; Brigitte Gansera
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-08-29

6.  Predictors for non-delayed discharge after transcatheter aortic valve replacement: utility of echocardiographic parameters.

Authors:  Tomoo Nagai; Hitomi Horinouchi; Yohei Ohno; Tsutomu Murakami; Katsuaki Sakai; Gaku Nakazawa; Koichiro Yoshioka; Yuji Ikari
Journal:  Int J Cardiovasc Imaging       Date:  2020-07-25       Impact factor: 2.357

Review 7.  Pre-procedural risk models for patients undergoing transcatheter aortic valve implantation.

Authors:  Glen P Martin; Matthew Sperrin; Mamas A Mamas
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

8.  A framework for meta-analysis of prediction model studies with binary and time-to-event outcomes.

Authors:  Thomas Pa Debray; Johanna Aag Damen; Richard D Riley; Kym Snell; Johannes B Reitsma; Lotty Hooft; Gary S Collins; Karel Gm Moons
Journal:  Stat Methods Med Res       Date:  2018-07-23       Impact factor: 3.021

Review 9.  Diabetes mellitus is associated with increased acute kidney injury and 1-year mortality after transcatheter aortic valve replacement: A meta-analysis.

Authors:  George S Mina; Priyanka Gill; Demiana Soliman; Pratap Reddy; Paari Dominic
Journal:  Clin Cardiol       Date:  2017-05-16       Impact factor: 2.882

10.  Comparison of contemporary risk scores for predicting outcomes after surgery for active infective endocarditis.

Authors:  Tom Kai Ming Wang; Timothy Oh; Jamie Voss; Greg Gamble; Nicholas Kang; James Pemberton
Journal:  Heart Vessels       Date:  2014-01-25       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.